The Diabetic Macular Edema industry is undergoing significant transformation driven by advancements in therapeutic interventions and increasing prevalence of diabetes-related complications. Market growth is propelled by evolving treatment modalities and increasing investment in innovative product development. Enhanced understanding of disease patho

The Chemotherapy Induced Neutropenia (CIN) market is witnessing a pivotal growth phase shaped by advancements in supportive care therapies and rising cancer prevalence globally. The evolving therapeutic landscape for neutropenia management underlines the increasing demand for effective granulocyte colony-stimulating factors (G-CSFs) and biosimilars